Newsmakers

Nextech AR (OTC: NEXCF) to Present at ESCP International Event With Google, IBM, Netflix, Salesforce

TORONTO, April 26, 2022—Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (“AR”) experience technologies and services today announced that […]

No Picture
Newsmakers

Cyngn (NASDAQ: CYN) Launches DriveMod Kit, a Fully-Equipped Autonomous Vehicle Hardware Integration Module

MENLO PARK, Calif., April 21, 2022—Cyngn (or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial enterprises, today announced the official launch of DriveMod Kit, a turnkey autonomous […]

Newsmakers

DeepMarkit (OTC: MKTDF) Announces Strategic Initiative to Explore the Minting of Renewable Energy Certificates

Renewable Energy Certificate market size was valued at US$12.7 billion in 2021, which is projected to reach US$100 billion by 2030 The Company’s MintCarbon.io platform has the capability of seamlessly facilitating the minting of RECs into NFTs as with […]

Healthcare

PharmaDrug (OTC: LMLLF) Advances Oncology Program with Filing of Provisional Patent Following Positive Findings for the Combination of PD-001 and Frontline Chemotherapy in Prostate Cancer Study

Provisional patent filed (April 14, 2022) to support use of PD-001 plus cabazitaxel for primary, metastatic and chemotherapy-resistant prostate cancer Final study results show that oral cepharanthine (PD-001) plus cabazitaxel combination therapy significantly reduced tumor […]

Newsmakers

Nextech AR (OTC: NEXCF) Launches Ground-Breaking Integrated SaaS Platform “Nextech Metaverse Suite”

This integration of the Company’s 3D and AR SaaS offerings in one login portal marks a major milestone with substantial SaaS revenue implications TORONTO, April 14, 2022—Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) […]

Newsmakers

LIXTE Biotechnology (NASDAQ: LIXT) Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

PASADENA, CA, April 12, 2022 — LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, announces that Professor René Bernards, Netherlands Cancer Institute (NKI), Amsterdam, presented new data […]

No Picture
Healthcare

Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy

— Independent Data Monitoring Committee Unanimously Recommends that Phase 3 Clinical Trial for Sabizabulin for Treatment of Hospitalized COVID-19 Patients at High Risk for ARDS Be Stopped Early Due to Overwhelming Evidence of Efficacy — […]